Postoperative Nausea and Vomiting
📧 Sign up to get email alerts when something new happens for Postoperative Nausea and Vomiting.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Postoperative Nausea and Vomiting: Ramosetron Plus Aprepitant vs Palonosetron Plus Aprepitant [NA]
Completed clinical trial comparing Ramosetron plus Aprepitant versus Palonosetron plus Aprepitant for postoperative nausea and vomiting.
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Dexamethasone for the Prevention of Post-operative Nausea and Vomiting in Patients Undergoing Cesarean Sections [Phase 4]
Phase 4 trial update evaluating dexamethasone to prevent post-operative nausea and vomiting in cesarean section patients; completed with res…
-
FDA approval · 2017-03-30FDA Approved: ONDANSETRON — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark Pharmaceuticals’ supplemental application for ondansetron (generic antiemetic) under ANDA077535.
-
FDA label_change · 2017-03-27FDA Approved: ONDANSETRON — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for ondansetron from PAI Pharma, resulting in changes to the product labeling.
-
FDA approval · 2017-03-27FDA Approved: ONDANSETRON — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for ondansetron submitted by Rising Pharma Holdings, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-03-24FDA Approved: ONDANSETRON — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approves a supplemental application for ondansetron from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2017-03-24FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for ondansetron hydrochloride from Sun Pharmaceutical Industries, Inc., under the ANDA.
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women [Phase 3]
Phase 3 trial evaluating casopitant with Zofran to prevent postoperative nausea and vomiting in women has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: Prophylactic Antiemetic Efficacy of Palonosetron Versus Ondansetron for Cesarean Sections Under Regional Anesthesia [Phase 4]
A Phase 4 trial comparing palonosetron and ondansetron for prophylaxis of postoperative nausea and vomiting in cesarean sections under regio…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Low Doses of Ketamine and Postoperative Quality of Recovery [Phase 4]
Phase 4 trial evaluating whether low-dose ketamine improves postoperative quality of recovery has completed and posted results.
-
CLINICAL_TRIALS research · 2017-03-03Clinical Trial Update: Risk Factors for Postoperative Nausea/Vomiting
Clinical trial update from Khon Kaen University on risk factors for postoperative nausea and vomiting; the study status is COMPLETED.
-
FDA approval · 2017-02-23FDA Approved: PROCHLORPERAZINE MALEATE — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
The FDA approved a supplemental application for Prochlorperazine maleate by Jubilant Cadista Pharmaceuticals Inc.
-
FDA approval · 2017-02-14FDA Approved: ONDANSETRON — Supplemental Application (ACTAVIS PHARMA, INC.)
The FDA approved a supplemental application for ondansetron tablets from Actavis Pharma, Inc. under the ANDA, signifying an approved change …
-
FDA approval · 2017-02-07FDA Approved: ONDANSETRON — Supplemental Application (AvPAK)
FDA approves a supplemental application for ondansetron submitted by AvPAK.
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Caffeine in the Prevention of Post-operative Nausea and Vomiting [NA]
A completed clinical trial evaluating caffeine for prevention of postoperative nausea and vomiting.
-
CLINICAL_TRIALS trial_result · 2017-01-25Clinical Trial Update: Dose-ranging Study of Ramosetron for the Prevention of Nausea and Vomiting After Gynecologic Laparoscopic Surgery [Phase 4]
This Phase 4 dose-ranging trial evaluated ramosetron for prevention of postoperative nausea and vomiting following gynecologic laparoscopic …
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: Study Of An NK-1 Anti-Emetic Medication For The Prevention Of Post-Operative Nausea And Vomiting In Female Patients [Phase 2]
Phase 2 trial update on an NK-1 receptor antagonist for prevention of postoperative nausea and vomiting in female patients; the study has co…
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: A Study To Evaluate An NK-1 Antiemetic For The Prevention Of Post Operative Nausea And Vomiting [Phase 2]
This entry notes the completion of a Phase 2 clinical trial evaluating an NK-1 antiemetic for prevention of postoperative nausea and vomitin…
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: Post-Operative Nausea And Vomiting Study In Female Patients [Phase 2]
Phase 2 clinical trial evaluating treatment for postoperative nausea and vomiting in female patients; the study has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Effect of Ramosetron on Bowel Motility After Gynecological Surgery [Phase 4]
Phase 4 clinical trial evaluating the effect of Ramosetron on bowel motility after gynecologic surgery for postoperative nausea and vomiting…
-
CLINICAL_TRIALS trial_result · 2016-12-30Clinical Trial Update: Effect of Dexamethasone Combined With Ondansetron on Postoperative Nausea and Vomiting in Patients With Patient-controlled Analgesia After Video-assisted Thoracoscopic Surgery [Phase 4]
Phase 4 trial completion evaluating dexamethasone plus ondansetron for prevention of postoperative nausea and vomiting in patients receiving…
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Prophylaxis of Postoperative Nausea and Vomiting After Cardiac Surgery [Phase 3]
A Phase 3 clinical trial assessing prophylaxis of postoperative nausea and vomiting after cardiac surgery has completed.
-
FDA approval · 2016-11-08FDA Approved: GRANISETRON HYDROCHLORIDE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for granisetron hydrochloride (generic) from Mylan Institutional LLC.
-
FDA approval · 2016-11-08FDA Approved: GRANISETRON HYDROCHLORIDE — Supplemental Application (Mylan Institutional LLC)
FDA approves a supplemental application for granisetron hydrochloride from Mylan Institutional LLC, expanding access for this generic antiem…
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Dexamethasone and Ondansetron Versus Placebo for Postoperative Nausea and Vomiting [Phase 4]
A Phase 4 trial evaluating dexamethasone and ondansetron versus placebo for postoperative nausea and vomiting has completed.